MYRF and sarcopenia: In particular, sarcopenia is exacerbated by activation of the TGF-β signaling pathway, whereas it is alleviated by activation of the IGF-1 signaling pathway, the BMP signaling pathway, and the MRF-related signaling pathway (Figure 1).